Barbara Hanney

Potent quinoxaline-Based inhibitors of PDGF receptor tyrosine kinase activity. Part 2: the synthesis and biological activities of RPR127963 an orally bioavailable inhibitor

Barbara Hanney, Alfred P. Spada, Glenda E. Bilder et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 151 citations · Full text

Maximizing Diversity from a Kinase Screen: Identification of Novel and Selective pan-Trk Inhibitors for Chronic Pain

Shawn J. Stachel, John M. Sanders, Darrell A. Henze et al. · Journal of Medicinal Chemistry · 2014 · 60 citations · Full text

Small Molecule Inhibitors, Drug Target, Pain Medicine +22

3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6

Mark E. Fraley, Justin T. Steen, Edward J. Brnardic et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 46 citations · Full text

Medicinal Chemistry, Medicine, Drug Discovery +9

Potent quinoxaline-Based inhibitors of PDGF receptor tyrosine kinase activity. Part 1: SAR Exploration and Effective Bioisosteric Replacement of a phenyl substituent

Michael R. Myers, Wei He, Barbara Hanney et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 44 citations · Full text

Sar Exploration, Medicinal Chemistry, Medicine +10

Discovery of [¹¹C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases

Ling Tong, Wenping Li, Michael Man‐Chu Lo et al. · Journal of Medicinal Chemistry · 2020 · 39 citations · Full text